Schedule of Common Stock Warrants (Details) - $ / shares |
6 Months Ended | 12 Months Ended |
|---|---|---|
Jun. 30, 2026 |
Dec. 31, 2025 |
|
| Share-Based Payment Arrangement [Abstract] | ||
| Number of warrants, outstanding beginning balance | 5,142,940 | |
| Weighted average exercise price, outstanding beginning balance | $ 5.11 | |
| Weighted average remaining contractual term | 3 years 9 months 18 days | 1 year 11 months 4 days |
| Number of warrants, granted | 11,975,071 | |
| Weighted average exercise price, granted | $ 0.79 | |
| Weighted average remaining contractual term, granted | 5 years | |
| Number of warrants, expired | (349,314) | |
| Weighted average exercise price, expired | $ 4.77 | |
| Number of warrants, outstanding ending balance | 16,768,697 | 5,142,940 |
| Weighted average exercise price, outstanding ending balance | $ 2.03 | $ 5.11 |
| Number of warrants, exercisable | 16,768,697 | |
| Weighted average exercise price, exercisable | $ 2.03 | |
| Weighted average remaining contractual term, exercisable | 3 years 9 months 18 days |
| X | ||||||||||
- Definition The number of shares into which fully or partially vested warrants outstanding as of the balance sheet date can be currently converted under the option plan. No definition available.
|
| X | ||||||||||
- Definition The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of warrants outstanding and currently exercisable under the warrants plan. No definition available.
|
| X | ||||||||||
- Definition Weighted average price at which grantees can acquire the shares reserved for issuance under the warrants plan. No definition available.
|
| X | ||||||||||
- Definition Weighted average price at which grantees could have acquired the underlying shares with respect to warrants of the plan that expired. No definition available.
|
| X | ||||||||||
- Definition Weighted average per share amount at which grantees can acquire shares of common stock by exercise of warrants. No definition available.
|
| X | ||||||||||
- Definition Weighted average remaining contractual term, exercisable. No definition available.
|
| X | ||||||||||
- Definition Weighted average remaining contractual term for non option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. No definition available.
|
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award non options outstanding weighted average remaining contractual term granted. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Number of shares under non-option equity instrument agreements for which rights to exercise lapsed. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Net number of non-option equity instruments granted to participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|